[1]
Fitria, N., Zazna Syaputri, Y., Lailaturrahmi, L. and Nasif, H. 2024. Observing the uncertainty of the Amlodipine-Candesartan Incremental Cost-Effectiveness ratio using Deterministic Sensitivity Analysis (DSA) . Journal of Health Economic and Policy Research (JHEPR). 2, 2 (Aug. 2024), 46–50. DOI:https://doi.org/10.30595/jhepr.v2i2.118.